Bristol Myers - Celgene CVRPreferred / convertible

13F holders, Q2 2025 (June 30)

Q2 2026Q1 2026Q4 2025Q3 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024

24holders +4

4new positions

0sold out

1famous investor

$0.11avg. 13F price*

At the end of Q2 2025, 24 institutions reported holding Bristol Myers - Celgene CVR in their 13F filings, up 4 from Q1 2025. 4 opened new positions and 0 sold out. The largest holders were Maven Securities LTD ($47K), Transcend Capital Advisors, LLC ($3K) and DAVENPORT & Co LLC ($2K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).

Company: Bristol Myers - Celgene CVR
CUSIP: 110122140
Latest filing quarter: Q2 2026

History

Number of 13F holders

Total Exit/New Position Q1 2025 → Q2 2025

	Institutions	Total Value
New Positions	4	$930
Exits	0	$0

All 13F filers, Q1 2025 → Q2 2025: 37,470 shares bought and 5,222 shares sold, net +32,248 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 24 holders


Maven Securities LTD	—	No change	67,856	$47K
Transcend Capital Advisors, LLC	—	No change	109,175	$3K
DAVENPORT & Co LLC	—	No change	83,970	$2K
Bank of America Corp.	—	Add +0.0%	51,828	$1K
Susquehanna International Group, LLP	—	New	37,102	$928
Citadel Advisors	—	Reduce -4.2%	35,388	$885
Watts Gwilliam & Co., LLC	—	No change	20,000	$668
Purkiss Capital Advisors LLC	—	No change	26,450	$661
Two Sigma Securities, LLC	—	Reduce -14.4%	21,991	$550
Fifth Third Bancorp	—	No change	20,000	$500
Private Advisor Group, LLC	—	No change	15,000	$375
UBS Group AG	—	Add +2.2%	13,450	$336
Northwestern Mutual Wealth Management Co.	—	No change	341	$8
Rothschild Investment LLC	—	No change	166	$4
Morgan Stanley	—	No change	119	$3
Oakworth Capital, Inc.	—	No change	125	$3
JPMorgan Chase & Co.	—	No change	23	$1
Raymond James Financial Inc.	—	New	50	$1
First Pacific Financial	—	New	6	$1
Atlantic Edge Private Wealth Management, LLC	—	No change	16	$1
Wells Fargo & Company	—	No change	28	$0
Royal Bank of Canada	—	No change	2,475	$0
Whittier Trust Co.	—	No change	25	$0
Pension & Wealth Management Advisors, Inc.	—	New	12	$0

"% of holder's portfolio" is BRISTOL MYERS - CELGENE CVR's weight in each manager's 13F, not the share of Bristol Myers - Celgene CVR the manager owns.